- Home
- ED vs IDXX Comparison
ED vs IDXX Comparison
Compare ED & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ED
- IDXX
- Stock Information
- Founded
- ED 1884
- IDXX 1983
- Country
- ED United States
- IDXX United States
- Employees
- ED N/A
- IDXX N/A
- Industry
- ED Power Generation
- IDXX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ED Utilities
- IDXX Health Care
- Exchange
- ED Nasdaq
- IDXX Nasdaq
- Market Cap
- ED 34.6B
- IDXX 35.5B
- IPO Year
- ED N/A
- IDXX 1991
- Fundamental
- Price
- ED $98.69
- IDXX $418.55
- Analyst Decision
- ED Hold
- IDXX Buy
- Analyst Count
- ED 15
- IDXX 7
- Target Price
- ED $96.39
- IDXX $545.29
- AVG Volume (30 Days)
- ED 2.2M
- IDXX 765.3K
- Earning Date
- ED 11-07-2024
- IDXX 10-31-2024
- Dividend Yield
- ED 3.38%
- IDXX N/A
- EPS Growth
- ED N/A
- IDXX 5.57
- EPS
- ED 5.31
- IDXX 10.36
- Revenue
- ED $15,031,000,000.00
- IDXX $3,844,817,000.00
- Revenue This Year
- ED $8.00
- IDXX $8.03
- Revenue Next Year
- ED $3.97
- IDXX $6.98
- P/E Ratio
- ED $18.53
- IDXX $40.43
- Revenue Growth
- ED N/A
- IDXX 7.16
- 52 Week Low
- ED $85.85
- IDXX $398.50
- 52 Week High
- ED $107.75
- IDXX $583.39
- Technical
- Relative Strength Index (RSI)
- ED 45.63
- IDXX 36.13
- Support Level
- ED $95.32
- IDXX $408.95
- Resistance Level
- ED $98.97
- IDXX $444.84
- Average True Range (ATR)
- ED 1.60
- IDXX 10.45
- MACD
- ED 0.06
- IDXX 0.89
- Stochastic Oscillator
- ED 67.26
- IDXX 43.27
About ED Consolidated Edison Inc.
Con Ed is a holding company for Consolidated Edison of New York, or CECONY, and Orange & Rockland, or O&R. These utilities provide steam, natural gas, and electricity to customers in southeastern New York—including New York City—and small parts of New Jersey. The two utilities generate nearly all of Con Ed's earnings following the sale of its clean energy business to RWE in early 2023.
About IDXX IDEXX Laboratories Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.